For several years, I have led numerous structured scientific collaborations with high-level laboratories and universities, both in France and internationally. These partnerships, consistently resulting in research publications, joint projects, or doctoral co-supervisions, are central to my research strategy. For example, my work has been conducted in partnership with prestigious institutions in China (Xidian, Hebei, Wuhan, Shanghai), Lebanon, Morocco, Canada, Mexico, Poland, and Togo, in addition to solid collaborations with IRCAD, CNRS, University of Lyon 1, University of Strasbourg, and UTBM. These cooperations enrich the scientific scope of our work, allow for the pooling of expertise, promote publication in Tier 1 (Q1) journals, and contribute directly to the training of young researchers. I am actively involved in their animation, consolidation, and development, convinced that science can only be built through openness, trust, and international cooperation.

Among my more than 200 scientific publications, a selection of works published in leading journals (Q1 rank, with high impact factors) illustrates the scope and rigor of my research. These articles, produced in collaboration with research teams in China, Canada, Mexico, and France, address complex issues such as home healthcare optimization, AI-assisted medical diagnosis, and risk analysis in public health. Each publication is the result of in-depth collaborative work within the framework of research projects, doctoral co-supervisions, or long-term institutional partnerships. Subjecting my work to international scrutiny, having it validated by demanding peer review committees, and disseminating it in high-impact scientific journals has always been a priority and a lever for scientific progress.

For over two decades, I have developed research activities rooted in strong collaborative dynamics, combining large-scale competitive projects and targeted industrial partnerships. The funded research projects (Europe, ANR, FEDER, BPI, Interreg, etc.) that I have coordinated, with a total amount exceeding 14 million euros, have allowed me to structure multidisciplinary ecosystems involving universities, hospitals, and companies around high-stake issues such as AI in health, medical telemonitoring, and care pathway optimization. In parallel, the industrial contracts I have signed have played a key role in anchoring academic research in field realities, generating concrete deliverables, publishing with partners, and integrating young PhDs into projects with high innovation potential.

These two levers are inseparable: academic projects offer scientific depth and collective dynamics, while industrial collaborations ensure relevance, application, and impact. Their coherent articulation constitutes, in my view, an essential condition for producing research that is both demanding, useful, and sustainable, making UTBM a key player in technology transfer and regional innovation.